Govt plans to launch cheaper biosimilars for diabetes, cancerPost published:July 3, 2017Post category:Industry NewsThe plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostTata Realty, StanChart PE JV buys Thane-Belapur land for Rs325 crore Next PostPharma firms yet to begin billing under new GST rates You Might Also Like New IIP series excludes calculators, gutka, TV picture tubes May 12, 2017 ABB announces Peter Voser as interim CEO as Ulrich Spiesshofer steps down April 17, 2019 Flipkart is e-commerce market leader in India, says Naspers report June 27, 2017